机构:[1]Peking University People’s Hospital, Beijing, China[2]Chinese PLA General Hospital, Beijing, China[3]Nanjing Drum Tower Hospital, Nanjing, China[4]Sir Run Run Shaw Hospital, Zhejiang University Medical College, Hangzhou, China[5]The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China[6]The First Affiliated Hospital of Chongqing Medical University, Chongqing, China重庆医科大学附属第一医院[7]Shanghai First People’s Hospital, Shanghai, China[8]West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[9]Peking University First Hospital, Beijing, China[10]Henan Provincial People’s Hospital, Zhengzhou, China[11]Beijing Novartis Pharma Co. Ltd, Beijing, China
第一作者机构:[1]Peking University People’s Hospital, Beijing, China
推荐引用方式(GB/T 7714):
Ji Linong,Pan Changyu,Lu Juming,et al.Vildagliptin add-on to metformin versus metformin uptitration in Chinese patients with type 2 diabetes: A sub-group analysis of the VISION study[J].DIABETES-METABOLISM RESEARCH AND REVIEWS.2015,31:1-1.
APA:
Ji, Linong,Pan, Changyu,Lu, Juming,Zhu, Dalong,Li, Hong...&Cai, Qin.(2015).Vildagliptin add-on to metformin versus metformin uptitration in Chinese patients with type 2 diabetes: A sub-group analysis of the VISION study.DIABETES-METABOLISM RESEARCH AND REVIEWS,31,
MLA:
Ji, Linong,et al."Vildagliptin add-on to metformin versus metformin uptitration in Chinese patients with type 2 diabetes: A sub-group analysis of the VISION study".DIABETES-METABOLISM RESEARCH AND REVIEWS 31.(2015):1-1